UroGen Pharma (URGN) announced that adult patients living with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer now have improved access to an important therapy, as the ...

Senate majority leader Bill Frist's surprise call for a two-year ad moratorium for newly approved prescription drugs greatly heightens pressure on the pharmaceutical industry to alter ...

BCD Meetings & Incentives last week launched an EMEA-wide Pharmaceutical Code Compliance Team to reassure clients it operates within the strict requirements governing meetings staged by pharmaceutical ...

Faced with growing criticism and increased regulation, the pharmaceutical industry has adopted a new code of ethics. Will this self-policing policy increase consumer safety, improve the industry’s ...